All Articles

CSTS Enterprises just tapped a top-tier academic for its advisory board. Here is why the future of mega-events like F1 and the World Cup relies on rigorous behavioral science.

As Chinese gaming giants deploy XR fashion and AI to court European creatives, the hidden costs of digital diplomacy come into forensic focus.

As B2B buyers demand rep-free exploration, Consensus unveils a unified AI platform, challenging traditional sales motions and presales software rivals.

As AI systems devour enterprise data, the line between privacy and algorithmic governance is vanishing. How one vendor is capitalizing on the regulatory shift.

Modern medicine’s greatest triumphs in oncology and rheumatology are inadvertently fueling a silent surge in Secondary Immunodeficiencies.

Alternative lenders are filling the void left by traditional banks. But do teaser rates and rapid approvals mask hidden risks for vulnerable UK businesses?

As traditional banking meets Web3, DogPay's new Enterprise Global Account reveals how Asian hubs are pioneering the next era of hybrid corporate treasury.

As regulatory scrutiny intensifies, tier-one banking executives are moving to AI vendors to build the next generation of autonomous compliance systems.

As adult wellness trends spill into the nursery, Australian brand Woven Woven capitalizes on the premiumization of pediatric sleep with bead-free knits.

As NEC Indonesia unveils its latest AI manufacturing tools in Jakarta, the real story lies in the strategic coalitions forming to balance automation with labor realities in Southeast Asia.

SailGP’s 100 km/h catamarans are coming to Victoria Harbour. We explore the tech, Amex's premium strategy, and Hong Kong's push for mega-event dominance.

Aiello's integration with Shiji Infrasys POS signals a major shift. Hotel AI is moving from answering basic questions to driving real F&B revenue.

Particula’s AAA rating for WisdomTree’s $1.2B tokenized fund signals a major shift in how Wall Street evaluates and trades blockchain-based assets.

As BEE Macau opens its doors, a massive joint venture brings AI-driven playing card manufacturing to the heart of Asia's gaming capital.

A new alliance between GCCL and LabConnect reveals how independent central labs are building global networks to challenge mega-CROs in clinical trial logistics.

Orum Therapeutics enters the clinic with a novel degrader-antibody conjugate, aiming to turn a historically toxic mechanism into a targeted lifeline for AML.

By building talent infrastructure before the factories even open, Ohio is aggressively positioning the Midwest to dethrone coastal biomanufacturing hubs.

As Helsinki secures a major UNESCO listing and invests in its civic infrastructure, the Finnish capital is exporting its human-centered design ethos to Japan.

The clinical-stage biotech's public debut tests investor appetite for immunology as it funds a novel Treg pipeline into 2029.

As Liberty Defense transitions from R&D to scaling its AI-powered weapons detection tech, COO Keith Teichmann steps up as Interim CEO to drive growth.